| Company Name: |
Tianjin Kailiqi Biotechnology Co., Ltd.
|
| Tel: |
15076683720 |
| Email: |
klq@cw-bio.com |
| Products Intro: |
Product Name:11β-HSD1-IN-12
CAS:872506-67-7
Purity:大于98% Package:1g,5g,10g,25g根据客户需要分装 Remarks:Not For Human Use, Lab Use Only.
|
| Company Name: |
DC Chemicals
|
| Tel: |
021-58447131 13564518121 |
| Email: |
sales@dcchemicals.com |
| Products Intro: |
Product Name:INCB13739
CAS:872506-67-7
Purity:98% HPLC Package:100mg，250mg，1g
|
| Company Name: |
Nanjing Shizhou Biology Technology Co.,Ltd
|
| Tel: |
025-85560043 15850508050 |
| Email: |
info@synzest.com |
| Products Intro: |
Product Name:(3S)-1-(3-Chloro-2-methylbenzene)sulfonyl-N-cyclohexylpiperidine-3-carboxamide
CAS:872506-67-7
Purity:95% Package:50mg；100mg
|
|
| | (3S)-1-[(3-chloro-2-methylbenzene)sulfonyl]-
N-cyclohexylpiperidine-3-carboxamide Basic information |
| | (3S)-1-[(3-chloro-2-methylbenzene)sulfonyl]-
N-cyclohexylpiperidine-3-carboxamide Chemical Properties |
| density | 1.29±0.1 g/cm3(Predicted) | | pka | 15.29±0.20(Predicted) |
| | (3S)-1-[(3-chloro-2-methylbenzene)sulfonyl]-
N-cyclohexylpiperidine-3-carboxamide Usage And Synthesis |
| Description | INCB13739 is a potent, selective, oral 11βHSD1 inhibitor (IC50=1.1 nM) for the treatment of type 2 diabetes. INCB-13739 has high selectivity for 11beta-HSD1 over other dehydrogenases and glucocorticoid and mineralocorticoid receptors, with prolonged pharmacodynamic activity and good pharmacokinetic/pharmacodynamic properties. INCB-13739 demonstrated improved hepatic and peripheral insulin sensitivity with a satisfactory reduction in fasting plasma glucose and cholesterol |
| | (3S)-1-[(3-chloro-2-methylbenzene)sulfonyl]-
N-cyclohexylpiperidine-3-carboxamide Preparation Products And Raw materials |
|